Stocktoria

TuHURA Biosciences, Inc./NV HURA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2016-07-12

TuHURA Biosciences, Inc./NV statistics & valuation

Market cap$137.6M
P / B6.6×
Return on equity-143.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2018201920202021202220232023202420242025
Operating margin (%)
2018201920202021202220232023202420242025
Return on equity (%)
204.90% -409.00% -3470.00% -362.00% -192.10% -2004.00% -148.60% -143.60% 2018201920202021202220232023202420242025
Shares outstanding
2.1M 2.6M 10.4M 25.9M 974000 1.6M 12.2M 26.4M 18.7M 59.3M 2018201920202021202220232023202420242025
Net debt ($)
-$6.0M 2018201920202021202220232023202420242025
Share buybacks ($)
2018201920202021202220232023202420242025
Return on assets (%)
157.40% -199.30% -310.60% -282.80% -142.10% -368.20% -672.10% -134.20% -108.60% -109.90% 2018201920202021202220232023202420242025
Free cash flow margin (%)
2018201920202021202220232023202420242025
Debt / equity (×)
0.00× 2018201920202021202220232023202420242025
EPS ($)
-$2.47 -$1.21 -$0.63 2018201920202021202220232023202420242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2024FY2023FY2023FY2022FY2021FY2020FY2019FY2018
Return on assets-109.9%-108.6%-134.2%-672.1%-368.2%-142.1%-282.8%-310.6%-199.3%157.4%
Return on equity-143.6%-148.6%119.6%1880.8%-2004.0%-192.1%-362.0%-3470.0%-409.0%204.9%
Debt / equity—————————0.00×
Current ratio0.783.682.451.161.063.324.241.071.944.30

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.